1993
DOI: 10.1016/0223-5234(93)90033-b
|View full text |Cite
|
Sign up to set email alerts
|

New calmodulin antagonists of the diphenylalkylamine type. I. Biological activity, SAR and the role of lipophilicity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

1993
1993
2009
2009

Publication Types

Select...
3
2
1

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(1 citation statement)
references
References 19 publications
0
1
0
Order By: Relevance
“…Chiral β,β-diaryl propionic acid derivatives and related compounds have significant and diverse biological activity. This structural element is present in compounds which have reported activities as antiarrhythmics, , vasodilators (Ca-modulin antagonists), , antidepressives, ,, antihistamines, and controllers of cerebral insufficiency . As such, synthetic methods are required for the preparation of a wide variety of compounds of this general structure, ,,,− especially in an optically pure form. , In this regard we were attracted to methodology developed by Alexakis involving stereoselective 1,4-addition of lithium diphenyl cuprate to α,β-unsaturated ethyl ester 1 possessing a neighboring chiral controller (chiral imidazolidine) …”
mentioning
confidence: 99%
“…Chiral β,β-diaryl propionic acid derivatives and related compounds have significant and diverse biological activity. This structural element is present in compounds which have reported activities as antiarrhythmics, , vasodilators (Ca-modulin antagonists), , antidepressives, ,, antihistamines, and controllers of cerebral insufficiency . As such, synthetic methods are required for the preparation of a wide variety of compounds of this general structure, ,,,− especially in an optically pure form. , In this regard we were attracted to methodology developed by Alexakis involving stereoselective 1,4-addition of lithium diphenyl cuprate to α,β-unsaturated ethyl ester 1 possessing a neighboring chiral controller (chiral imidazolidine) …”
mentioning
confidence: 99%